Agios Pharmaceuticals, Inc. (AGIO) Q4 2022 Earnings Call Transcript

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2022 Earnings Conference Call February 23, 2023 8:00 AM ET

Company Participants

Jessi Rennekamp - Senior Director, Corporate Communications
Brian Goff - CEO
Sarah Gheuens - CMO & Head, R&D
Tsveta Milanova - CCO
Cecilia Jones - CFO

Conference Call Participants

Chris Raymond - Piper Sandler
Marc Frahm - Cowen
Mary Kate - Bank of America
Tessa Romero - J.P. Morgan
Greg Renza - RBC
Mark Breidenbach - Oppenheimer
Danielle Brill - Raymond James

Operator

Good morning, and welcome to Agios Fourth Quarter and Year-End 2022 Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end. Please be advised that this call is being recorded at Agios request.

I would now like to turn the call over to Jessi Rennekamp, Senior Director of Corporate Communications. Please go ahead.

Jessi Rennekamp

Thank you, Operator. Good morning, everyone, and welcome to Agios fourth quarter and year-end 2022 conference call. You can access slides for today's call by going to the Investors section of our website, agios.com.

With me on the call today with prepared remarks are Brian Goff, our Chief Executive Officer; Dr. Sarah Gheuens, our Chief Medical Officer and Head of Research and Development; Tsveta Milanova, our Chief Commercial Officer; and Cecilia Jones, our Chief Financial Officer.

Before we get started, I would like to remind everyone that some of the statements we make on this call will include forward-looking statements. Actual events and results could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties and other factors, including those set forth in our most recent filings with the SEC and any other future filings that we may make with the SEC.

With that, I will turn